Foluso O Ademuyiwa

22PUBLICATIONS
200CO-AUTHORS
Epidemiological methodsCancer diagnosisTumour immunologyMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Jun 22, 2026
Impact of Financial Incentives on Electronic Health Record-Driven Recruitment of Underrepresented Communities in Research: Randomized Controlled Trial.

|Apr 17, 2026
Spatial Mapping of the Precancer-to-Cancer Transition in Breast and Prostate.

|Feb 06, 2026
Neoadjuvant Endocrine Treatment plus Mammaglobin-A DNA Vaccine Induces Antitumor Immune Responses in the Primary Tumor and Peripheral Blood of Patients with Breast Cancer: Insights from a Phase Ib Clinical Trial.

Rashmi Mishra, Foluso Ademuyiwa, Yilin Yang

|Jan 27, 2026
Biomarkers of response to neoadjuvant palbociclib plus anastrozole in endocrine-resistant estrogen receptor-positive/HER2-negative breast cancer: a phase 2 trial.

Tim Kong, Alex Mabry, Maureen Highkin

|Mar 21, 2025
Detection of Circulating Tumor DNA Using a Tissue-Free Epigenomic Assay Is a Highly Prognostic Biomarker in Early-Stage Triple-Negative Breast Cancer.

Foluso O Ademuyiwa, Cynthia X Ma, Katherine Weilbaecher

|Oct 31, 2024
Differential chromatin accessibility and transcriptional dynamics define breast cancer subtypes and their lineages.

Michael D Iglesia, Reyka G Jayasinghe, Siqi Chen

Pageof 4

Frequent Collaborators

8 joint publications

Cynthia X Ma

5 joint publications

Jingqin Luo

5 joint publications

Ian S Hagemann

4 joint publications

John M Herndon